12:32 PM EST - Ambrilia Biopharma Inc. : plans to sell at least $15.6 million worth of units, each made up of one common share and a half purchase warrant, to fund clinical trials and development of two cancer drugs. Ambrilia Biopharma Inc.
shares T.AMB are trading unchanged at $1.33.
